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Biochemical Mechanisms of IL-2±Regulated
Fas-Mediated T Cell Apoptosis
activation. Furthermore, Fas-mediated AICD is potenti-
ated by IL-2 (Lenardo, 1991), which is a surprising find-
ing, given that IL-2 is traditionally thought tobe a survival
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ally be required for triggering this death pathway, be-Department of Pathology
cause T cells from knockout mice lacking IL-2 (KneitzBrigham and Women's Hospital
et al., 1995) or the a chain of the IL-2 receptor, CD25and Harvard Medical School
(Van Parijs et al., 1997), are resistant to AICD. KnockoutBoston, Massachusetts 02115
mice lacking IL-2 or the a or b chain of the IL-2 receptor²Department of Biology
develop severe lymphoproliferation and manifestationsMassachusetts Institute of Technology
of autoimmunity (Sadlack et al., 1993; Suzuki et al., 1995;Cambridge, Massachusetts 02139
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cytokine in lymphocyte homeostasis.Lausanne Branch
The biochemical pathway of Fas signaling had beenUniversity of Lausanne
analyzed extensively in a variety of cell lines and trans-CH 1066 Epalinges
fectants, providing a framework for investigation of theSwitzerland
regulation of this pathway by IL-2. In the simplest
scheme, Fas signaling is initiated by oligomerization of
the receptor by FasL (Nagata, 1997). The cytoplasmic
domain of cross-linked Fas then binds the adaptor mole-Summary
cule FADD/MORT-1 via a protein±protein interaction do-
main (Boldin et al., 1995; Chinnaiyan et al., 1995). ThisActivation-induced cell death (AICD) of lymphocytes
is followed by the binding of another protein, FLICE/is an important mechamism of self-tolerance. In CD41
MACH-1 (caspase-8), which also has a protein interac-T cells, AICD is mediated by the Fas pathway and is
tion domain, and a separate caspase domain (Boldin etenhanced by IL-2. To define the mechanisms of this
al., 1996; Muzio et al., 1996). The caspase is activated,pro-apoptotic action of IL-2, we analyzed CD41 T cells
leading to a cascade of catalytic activation of caspasesfrom wild-type and IL-22/2 mice expressing a trans-
that culminates in apoptosis.genic T cell receptor. T cells become sensitive to AICD
The process can be inhibited by a FLICE-like inhibitorafter activation by antigen and IL-2. IL-2 increases
protein, FLIP, which was discovered as a viral producttranscription and surface expression of Fas ligand
(Golstev et al., 1997; Hu et al., 1997; Shu et al., 1997;(FasL) and suppresses transcription and expression
Srinivasula et al., 1997; Thome et al., 1997) and laterof FLIP, the inhibitor of apoptosis. The ability of IL-2
shown to exist in mammalian cells (Irmler et al., 1997).to enhance expression of a pro-apoptotic molecule,
The resistance of naive T cells to AICD has been attrib-FasL, and to suppress an inhibitor of Fas signaling,
uted to high levels of intracellular FLIP, which competi-FLIP, likely accounts for the role of this cytokine in
tively inhibits the binding of FLICE and shuts off Faspotentiating T cell apoptosis.
signaling (Irmler et al., 1997). However, insome cell lines,
FLIP has been shown to induce apoptosis (Shu et al.,
Introduction 1997), suggesting that its actions may be complex. Al-
though some studies suggest that anti-apoptotic mem-
Apoptotic death of lymphocytes is an important homeo- bers of the Bcl family can also block Fas-mediated apo-
static mechanism in the immune system and is involved ptosis (Boise and Thompson, 1997), recent biochemical
in the maintenance of peripheral tolerance to self anti- and functional analyses indicate that Bcl-regulated apo-
gens. One form of apoptosis is induced by repeated ptosis is a pathway different from Fas-mediated death,
stimulation of lymphocytes and is called activation- and the anti-apoptotic actions of Bcl-2 and Bcl-XL are
induced cell death (AICD). In CD41 T cells, AICD results probably proximal to the activation of caspases (Chin-
from coexpression of the death receptor, Fas (CD95), naiyan et al., 1997; Susin et al., 1997; Vander Heiden et
and its ligand, FasL (CD95L) (Brunner et al., 1995; Dhein al., 1997).
et al., 1995; Ju et al., 1995). Mutations in Fas or FasL In view of this likely sequence of events in Fas-medi-
result in systemic lupus-like autoimmune disease in ated AICD, one can hypothesize that IL-2 potentiates
AICD either by up-regulating levels of the pro-apoptoticmice (Nagata and Suda, 1995) and humans (Fisher et
proteins of the Fas signaling complex or by suppressingal., 1995; Rieux-Laucat et al., 1995), illustrating the criti-
expression of the inhibitors. To address this question,cal role of this death pathway in the maintenance of
it was necessary to establish the biochemical featuresself-tolerance.
of Fas signaling in normal, IL-2±responsive T cells, sinceA striking feature of Fas-mediated apoptosis is that
much of the earlier analysis was done with tumor linesit is tightly regulated, since it is dependent on prior
that are not responsive to physiologic stimuli such as
IL-2. The model system we chose uses mice expressing
a transgenic T cell receptor (TCR), called 3A9, specific§To whom correspondence should be addressed (e-mail: aabbas@
rics.bwh.harvard.edu). for the hen egg lysozyme (HEL) peptide 46-61 plus I-Ak,
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Figure 1. T Cell Activation and IL-2 Are Re-
quired for AICD in CD41 T Cells
The cell populations compared were (A)
freshly harvested (naive) 3A9 CD41 T cells
and cells activated for 3 days with HEL(46-
61) peptide plus APCs, with IL-2 (50 U/ml);
(B) 3A9/IL-22/2 T cells activated for 3 days
with antigen plus APCs, with or without IL-2;
and (C) wild-type and IL-22/2 3A9 T cells acti-
vated and restimulated, with or without IL-2.
To induce AICD, cells were cultured in wells
coated with anti-CD3, or incubated with anti-
Fas and cultured in wells coated with an anti-
hamster IgG antibody (A and B only), in the
presence or absence of 50 U/ml IL-2. After
approximately 20 hr, cell death was deter-
mined by propidium iodide staining. Data
shown are from one representative experi-
ment of three (A and B) or pooled from three
experiments (C).
bred into an IL-22/2 background. The advantage of this T cells and activated wild-type 3A9 T cells and 3A9/IL-
system is that normal function can be restored simply 22/2 T cells with the cognate peptide HEL(46-61) and
by adding IL-2 to the T cells. In this article we show syngeneic splenocytesas antigen-presentingcells (APCs),
that IL-2 is a transcriptional activator of FasL and a with or without added IL-2. Naive and activated T cells
transcriptional inhibitor of FLIP. This finding demon- were then exposed to anti-CD3 or anti-Fas antibody
strates that a cytokine can exert simultaneous and op- with or without IL-2, and apoptosis was assayed approx-
posite effects on the expression of pro-apoptotic and imately 20 hr later.
anti-apoptotic proteins and is the likely molecular expla- Recently activated, but not naive, T cells undergo
nation for the critical role of IL-2 in potentiating Fas- apoptosis upon exposure to anti-CD3 or upon direct
mediated AICD. cross-linking of Fas (Figure 1A). Similarly, IL-22/2 T cells
show markedly increased sensitivity to apoptosis if they
are first activated in the presence of IL-2 (Figure 1B).Results
More detailed analysis of the role of IL-2 showed that
activated wild-type 3A9 T cells die upon restimulationActivated IL-22/2 CD41 T Cells Are Resistant
with anti-CD3, with or without additional IL-2, presum-to Fas-Mediated AICD
ably because the cells themselves produce IL-2. In strik-The sensitivity of T cells to Fas-mediated AICD is tightly
ing contrast, the 3A9/IL-22/2 T cells undergo AICD onlyregulated, since it is dependent on prior activation (Irm-
if IL-2 is added both during the activation (priming) stageler et al., 1997; Peter et al., 1997) and on IL-2±induced
and the effector stage, at which AICD is induced bysignals (Lenardo, 1991; Kneitz et al., 1995; Van Parijs et
repeated engagement of the TCR (Figure 1C). Kinetical., 1997). To establish the conditions that make T cells
sensitive to AICD, we isolated naive 3A9 TCR transgenic analysis showed that approximately 3 days of activation
IL-2 Regulation of Fas Signaling
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Effect of Cell Activation and IL-2 on the Expression
of Fas and FasL
T cell activation and IL-2 may induce sensitivity to AICD
by enhancing expression of the death receptor, Fas, or
its ligand, FasL. To test this possibility, naive T cells and
cells activated with or without IL-2 were stained with
antibodies to Fas and FasL and analyzed by flow cytom-
etry. Naive wild-type T cells express modest levels of
Fas and undetectable FasL in response to 20 hr of stimu-
lation with anti-CD3. Prior activation with antigen and
APCs has a small effect on Fas, but markedly increases
FasL expression (Figure 2A). In IL-22/2 T cells, activation
with IL-2 has little effect on Fas but increases FasL
expression (Figure 2B). Therefore, one effect of T cell
activation and IL-2 is to increase FasL expression upon
restimulation.
To determine whether this IL-2±stimulated increase
of FasL expression is due to enhanced transcription,
3A9/IL-22/2 T cells were activated with a combination
of anti-CD3 and anti-CD28 antibodies with or without
IL-2 for 3 days. Aliquots of cells were harvested daily,
and RNA was extracted and assayed for FasL transcripts
by reverse transcriptase polymerase chain reaction (RT-
PCR). As shown in Figure 2C, in the absence of IL-2, FasL
RNA is detected within 3 days of activation, whereas in
the presence of IL-2, FasL transcripts are present within
1 day of stimulation. Naive cells (day 0) do not contain
detectable FasL mRNA. Thus, IL-2 is not absolutely re-
quired for FasL expression, but it markedly enhances
the rate and levels of expression.
Figure 2. Effect of Cell Activation and IL-2 on Expression of Fas
Although a deficiency of FasL may account in partand FasL
for the AICD-resistant phenoype of IL-22/2 T cells, this(A and B) Naive and in vitro activated 3A9 CD41 T cells (A) and 3A9/
cannot be the sole explanation, because IL-22/2 T cellsIL-22/2 T cells activated with or without IL-2 (B) were restimulated
do not die upon direct cross-linking of Fas, which by-in wells coated with anti-CD3 for 8 hr, stained with antibodies against
Fas and FasL or a control antibody (dotted line in all histograms) passes FasL (Figure 2B). We therefore postulated that
and analyzed by flow cytometry. The expression of these proteins the action of IL-2 must be distal to Fas engagement and
on gated CD41 cells is shown. involves either formation of theFas-associated signaling
(C) CD41 cells from 3A9/IL-22/2 mice were activated with antibodies
complex or the expression of inhibitors of the Fasto CD3 and CD28, with or without 50 U/ml IL-2. Cells were harvested
pathway.at indicated times, and RNA was prepared from all samples, reverse
transcribed, amplified using primers specific for FasL and b-actin,
and electrophoresed in 2% agarose gels.
IL-2 Is Not Required for Association of FADD
with Cross-Linked Fas
To establish that we could specifically detect FADD inin the presence of endogenously produced or exoge-
nously added IL-2 is required to make cells sensitive to association with cross-linked Fas by immunoprecipita-
tion and Western blotting, we activated wild-type andAICD (data not shown). Moreover, sensitivity to Fas-
mediated AICD is also acquired by activating T cells gld T cells with anti-CD3, immunoprecipitated Fas, and
probed blots with a rabbit anti-FADD antibody. Fas-with anti-CD3 plus anti-CD28 antibodies in the presence
of IL-2 (Van Parijs et al., 1996, and data not shown). This associated FADD was detected in wild-type but not in
gld T cells (data not shown), presumably because theactivation protocol is particularly useful when T cells
need to beanalyzed without the potentially complicating mutant FasL cannot transduce apoptotic signals through
Fas. We then examined this association in 3A9/IL-22/2influence of APCs. Phenotypic analysis showed that
both wild-type and IL-22/2 3A9 T cells down-regulate T cells activated in the presence and absence of IL-2.
As shown in Figure 3, FADD associates with Fas uponL-selectin and up-regulate CD69 upon activation, indi-
cating that they respond comparably to antigen (data cross-linking, either by anti-CD3 indirectly (via induced
FasL), or directly by cross-linking with anti-Fas, in T cellsnot shown).
These results show that in the absence of IL-2, CD41 that are activated with or without IL-2. The amount of
Fas-associated FADD is apparently increased by IL-2.T cells are activated by antigen but do not acquire sensi-
tivity to Fas-mediated AICD, and normal sensitivity can We do not know whether this is because IL-2 enhances
the synthesis of FADD or promotes the formation of thebe restored by culturing the cells in the presence of IL-2.
Therefore, this experimental model provides a system death-inducing signaling complex. However, IL-2 is not
required for association of the proximal components offor analyzing the mechanisms of IL-2 regulation of the
Fas-mediated death pathway. the complex. We have not yet examined association
Immunity
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Figure 3. The Association of FADD with Fas Does Not Require IL-2
3A9/IL-22/2 CD41 T cells were activated with HEL(46-61) peptide
plus APCs, alone or with 50 U/ml of IL-2, for 3 days. Activated cells
were incubated on anti-CD3±coated plates for 6 hr at 378C or with
anti-Fas antibody (Jo2) or control hamster IgG, followed by a mouse
anti-hamster IgG antibody for 30 min; washed; and incubated at
378C for 10 min. Cells were lysed in 0.1% Brij56 and lysates immuno-
precipitated with an anti-Fas antibody. A 12% SDS-PAGE gel was
run and blotted for Fas, and a 15% SDS-PAGE gel was run and
blotted for FADD.
of the third component of the death complex, FLICE,
because a reliable antibody specific for murine FLICE
is not available.
We also asked whether IL-2 affects transcription of
various components of the Fas signaling complex. RNase Figure 4. T Cell Activation and IL-2 Increase Transcription of FADD
protection assays showed that the levels of FADD and and FLICE
FLICE are moderately increased by day 3 of activation CD41 cells from 3A9/IL-22/2 mice were activated with antibodies to
and that this increase is enhanced by IL-2 (Figure 4). In CD3 and CD28, with or without 50 U/ml IL-2. Cells were collected
on days 1 and 3. RNA was extracted and used for RNAse protectionaddition, the levels of FasL transcript observed in these
using the mAPO-3 probe kit (PharMingen) and developed by autora-assays reflect those detected by RT-PCR (Figure 2C).
diography for 6 hr. By densitometry and scanning comparison with
control probes (GAPDH and L32), the levels of FLICE RNA increased
T Cell Activation in the Presence of IL-2 Suppresses about 2-fold over that in the starting population in cells activated
Transcription and Synthesis of FLIP for 3 days with IL-2; levels of FasL RNA increased by about 4-fold;
Since the proximal steps in the formation of the death and levels of Fas and FADD RNAs increased less than 1.5-fold. d,
day.complex are not dependent on IL-2, we postulated that
IL-2 may function by removing inhibitors of the Fas path-
way. The first such inhibitor we examined is FLIP, be- antigen and APCs, leads to the complete disappearance
cause its critical role in regulating sensitivity to AICD of FLIPmRNA. This suggests that IL-2 isa transcriptional
has been demonstrated in numerous recent studies (Hu inhibitor of FLIP. Western blot analysis of whole-cell
et al., 1997; Irmler et al., 1997; Thome et al., 1997). 3A9/ lysates, using an anti-FLIP antibody, showed that intra-
IL-22/2 T cells were activated in the presence or absence cellular FLIP protein also persists in T cells activated
of IL-2 for 3 days, and aliquots were cultured with IL-2 without IL-2 but is lost by 3 days of activation with IL-2
for an additional 48 hr. RNA was extracted at different (Figure 5B).
times during the cultures and assayed for FLIP mRNA
by RT-PCR. As shown in Figure 5A, in the absence of Constitutive Expression of FLIP Inhibits AICD
IL-2, high levels of FLIP mRNA are present throughout in T Cells
the 3 day activation. Addition of IL-2 during the initial These experiments strongly suggest that the resistance
of IL-22/2 T cells to AICD is due to the presence of FLIPactivation, or in a second culture after activation with
IL-2 Regulation of Fas Signaling
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Figure 5. FLIP Transcription and Synthesis Are Suppressed by IL-2
CD41 cells from 3A9/IL-22/2 mice were activated with antibodies to CD3 and CD28, with or without 50 U/ml IL-2.
(A) RNA was assayed by RT-PCR using primers specific for for FLIP and b-actin. Lanes 5±7 and lanes 11 and 12 contain RT-PCR products
obtained from cells that were activated for 3 days without or with IL-2 and then cultured with 50 U/ml IL-2 for the indicated times. d, day.
(B) Whole-cell lysates from 3A9/IL-22/2 T cells activated with anti-CD3 plus anti-CD28 with or without IL-2 were electrophoresed and Western
blots probed with anti-FLIP followed by anti-rabbit IgG-HRP. The top band is a nonspecific band that serves as an internal control for protein
loading.
in these cells. However, the issue is complicated by Discussion
findings in some cell types that FLIP may be an inducer
The principal goal of this study was to analyze the mech-of apoptosis (Shu et al., 1997). Therefore, we wanted
anisms by which IL-2 potentiates Fas-mediated apopto-to establish whether FLIP functions as an inhibitor or
sis in T cells. Using T cells from TCR transgenic miceinducer of AICD in normal, activated T cells. Murine
lacking IL-2, we show that this cytokine has two impor-and human T cell lines stably transfected with FLIP are
tant actions that regulate sensitivity to Fas-mediatedresistant to Fas-mediated AICD (L. V. P. and J. T., unpub-
AICD. First, IL-2 enhances the transcription and surfacelished data), suggesting that FLIP functions predomi-
expression of FasL (Figure 2). The induction of FasL isnantly as an inhibitor of this pathway of cell death in T
known to require TCR engagement (Combadiere et al.,cell lines. To determine the effects of FLIP in an IL-2±
1996), indicating that TCR signals and IL-2 generatedregulated pathway of AICD, we used a retroviral gene
signals cooperate to induce maximal levels of FasL. Astransfer system to express FLIP cDNA in activated wild-
a result, T cell activation in the presence of IL-2 is re-type 3A9 T cells. The retrovirus construct used expresses
quired for maximal cross-linking of Fas by endogenouslyboth FLIP and human placental alkaline phosphatase
synthesized FasL. However, this cannot be the only ac-(PLAP) from a dicistronic transcript (see Experimental
tion of IL-2, because in the absence of IL-2 T cells doProcedures), so that PLAP can be used as a surface
not become sensitive to apoptosis induced by directlymarker to identify infected T cells and as an indicator
cross-linking Fas, without a requirement for endoge-of the levels of retrovirus-derived FLIP present in individ-
nous FasL (Figure 1). IL-2 is not essential for the recruit-
ual T cells. Following infection with the FLIP-expressing
ment of the adaptor molecule, FADD, to oligomerized
retrovirus, MSCV-FLIP-IRES-PLAP, activated 3A9 T cells
Fas (Figure 3), indicating that it does not play an obliga-
that express high levels of PLAP are resistant to AICD tory role in the formation of the Fas signaling complex.
(39.3% 6 8.2% apoptotic cells in two representative The second important action of IL-2 is to suppress the
experiments; Figure 6) compared to cells that express transcription of the inhibitor of Fas-mediated apoptosis,
low levels of PLAP (79.8% 6 5.6% apoptotic cells). T FLIP (Figure 5). Thus, the prediction is that in wild-type
cells that have been infected with a control virus, MSCV- T cells, oligomerized Fas associates with FADD and
IRES-PLAP, that does not contain FLIP remain sensitive the caspase FLICE, whereas in the absence of IL-2 the
to AICD, independent of PLAP expression (PLAPhi cells complex consists of Fas, FADD, and the inhibitor, FLIP.
show 60.2% 6 3.9% apoptosis and PLAPlo cells show Formal establishment of this difference will require anti-
76.5% 6 4.7% apoptosis in two representative experi- bodies specific for murine FLICE and FLIP, and these
ments; Figure 6). These data support the hypothesis are currently being generated and tested.
that in primary T cells, FLIP functions as an inhibitor of The mechanisms by which IL-2 enhances FasL tran-
scription and inhibits FLIP transcription are not known.IL-2±regulated AICD.
Immunity
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Figure 6. Retrovirus-Mediated Expression of FLIP Protects Activated T Cells from AICD
CD41 cells from wild-type 3A9 mice were activated for 3 days with antibodies to CD3 and CD28 with 50 U/ml IL-2 and infected with a FLIP-
expressing retrovirus (MSCV-FLIP-IRES-PLAP) or a control virus (MSCV-IRES-PLAP). To induce AICD, the activated T cells were cultured in
wells coated with anti-CD3 in the presence of 50 U/ml IL-2. After approximately 20 hr, cell death was determined by staining with an antibody
against PLAP (to distinguish infected and non-infected cells) and TUNEL. Histograms show the expression of PLAP on all cells, the gates
used to identify infected cells, and the TUNEL staining profile of PLAPhi (infected) cells. Numbers in histograms are the percentage of cells
that are TUNEL-positive (apoptotic). Results shown are from one representative experiment of two, each done in duplicate. Mock transfections
yielded no PLAP1 cells (data not shown).
The FasL promoter (Latinis et al., 1997) contains a con- of other cytokines but that the pro-apoptotic effects
cannot (Fournel et al., 1996; Van Parijs et al., 1997). Thissensus binding site for the IL-2±induced signal trans-
ducer and activator of transcription, STAT5 (Lin et al., would explain the accumulation of activated and cycling
cells in mice deficient in IL-2 or IL-2 signaling. Also1995), but we do not know whether this is involved in
FasL transcriptional activation. In fact, it has recently consistent with this hypothesis is our finding that IL-2
inhibits transcription of FLIP, but IL-4 does not (databeen shown that STAT5a knockout mice do not have a
defect in superantigen-inducedT cell deletion (Nakajima not shown). High concentrations of cytokines other than
IL-2 may promote AICD under some conditions as longet al., 1997), which is largely due to Fas-mediated AICD.
The ability of IL-2 to shut off FLIP transcription is per- as they are able to drive cells into cycle (Zheng et al.,
1998). In any event, it is now clear that IL-2 is capablehaps even more intriguing and is difficult to explain
based on current understanding of cytokine-induced of inducing lymphocyte death as well as growth. It may
be that the growth-promoting activity of this cytokine istranscription factors.
Our results and studies from other laboratories (Irmler dominant early during an immune response, and if T cell
stimulation is persistent or IL-2 concentrations increaseet al., 1997; Peter et al., 1997) have clearly shown that
T cell activation is required for triggering Fas-mediated above a threshold, the potentiation of AICD becomes
dominant, leading to feedback regulation of the immuneAICD. Naive T cells express low levels of FasL and high
levels of FLIP (Figures 2 and 5), which is strikingly similar response. Defining the dual functions of this cytokine will
require better understanding of the biochemical signalsto the situation in IL-22/2 T cells. This suggests that
during T cell activation, the critical factor that induces used by IL-2 to promote T cell proliferation versus apo-
ptosis.sensitivity to AICD is IL-2 itself.
The finding that IL-2 promotes T cell death seems
paradoxical, considering that its first and most clearly Experimental Procedures
established function is as a growth and survival factor.
MiceThe unregulated lymphoid accumulation seen in mice
IL-22/2 mice (Sadlack et al., 1993) were obtained from the Jacksonlacking IL-2 suggests that the major obligatory function
Laboratory (Bar Harbor, ME). Mice expressing the transgenic 3A9
of this cytokine may be in T cell homeostasis. In fact, we TCR, specific for HEL(46-61) in association with I-Ak, were obtained
and others have suggested that the growth-promoting from Mark Davis (Stanford University Medical School, Stanford, CA).
These mice were backcrossed with IL-22/2 mice and interbred toeffects of IL-2 can be replaced by physiological levels
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produce TCR transgenic wild-type (3A91, IL-21/1 or IL-21/2) and at 728C, and40 cycles of thissequence. All reactions wereperformed
in an MJ-Research thermal cyler. The oligonucleotides used to am-knockout (3A91, IL-22/2) H-2k offspring. Progeny were genotyped
by PCR using the followingprimers: 3A9 transgene (59-GCAGTCACC plify murine FasL were 59-CAGCTCTTCCACCTGCAGAAGG-39, and
59-AGATTCCTCAAAATTGATCAGAGAGAG-39; for murine b-actin,CAAAGCCCAAG-39 and 59-CCCCAGCTCACCTAACACTG-39) and
IL-2 null allele (59-TCGAATTCGCCAATGACAAGACGCT-39, 59-CTAG 59-TGGAATCCTGTGGCATCCATGAAAC-39 and 59-TAAAACGCAGC
TCAGTAACAGTCCG-39; and for murine FLIP, 59-GTCACATGACATAGCCACAGAATTGAAAGATCT-39, and 59-GTAGGTGGAAATTCTAG
GATCATCC-39). All mice used in these experiments were 3±4 weeks ACCCAGATTGT-39 and 59-GTACAGACTGCTCTCCCAAGCACT-39.
PCR products were run on 2% agarose±Tris-borate-EDTA gels andold and were maintained in accordance with the guidelines of the
Committee on Animals of Harvard Medical School and those of stained with ethidium bromide (Sigma).
the Institute of Laboratory Animal Resources, National Research
Council. Immunoprecipitations and Western Blots
The immunoprecipitations for Fas were done by lysing 107 activated
T cells in 1 ml of Brij56 lysis buffer (100 mM NaCl, 20 mM Tris [pHT Cell Purification and In Vitro Activation
7.4], 0.1% Brij56 [Pierce, Rockford IL]), freshly supplemented withNaive CD41 TCR transgenic T cells were purified as described else-
a small protease inhibitor cocktail containing 2 mg/ml of aprotinin,where (Van Parijs et al., 1998). In brief, pooled lymph node and
2 mg/ml leupeptin, 2 mg/ml pepstatin A, 100 mg/ml phenylmethylsul-spleen cells harvested from 3A9 TCR transgenic animals were incu-
fonyl fluoride (all Boehringer Mannheim, Indianapolis, IN), 10 mMbated with anti-CD4±coated magnetic beads (Dynal, Oslo, Norway)
sodium orthovanadate, 10 mM sodium fluoride, and 10 mM sodiumfor 45 min at 48C. The adherent cells were washed twice and incu-
pyrophosphate (all Sigma). Cells were lysed on ice for 20 min andbated for 45 min at 48C with the Dynal Detach antibody. For in vitro
centrifuged at 12,000 rpm for 10 min at 48C. Clear supernatantsactivation, 2 3 105 naive CD41 T cells were cultured with 2 3 106
were transfered to a fresh 1.5 ml Eppendorf tube and incubatedmitomycin C (Sigma, St. Louis, MO) treated H-2k spleen cells in the
with a hamster anti-mouse Fas antibody (Jo2, PharMingen), on apresence of 1 mg/ml of HEL(46-61) peptide, with or without 50 U/ml
rocker at 48C for 1 hr. Recombinant protein G±agarose beadsIL-2, in a total volume of 1 ml of RPMI 1640 supplemented with 10%
(Gibco±BRL), which had been recently equilibrated in fresh Brij56heat inactivated fetal calf serum (Sigma); L-glutamine, penicillin,
lysis buffer, supplemented with protease inhibitors, were added tostreptomycin, nonessential amino acids, and sodium pyruvate, all
the tubes (40 ml of bead suspension per tube) and incubated for 1at 2 mM; 10 mM HEPES (all from Gibco±BRL Laboratories, Grand
hr at 48C on a rocker. At the end of this incubation period, samplesIsland, NY), and 5 3 1025 M 2-mercaptoethanol. To activate T cells
were washed five times for 5±10 min each in Brij56 lysis buffer,without APCs, 106 CD41 cells were cultured with 1 mg/ml of soluble
supplemented with protease inhibitors, and boiled for 5 min in 50anti-CD3 antibody (2C11) and 10 mg/ml of soluble anti-CD28 (37N1),
ml of 23 sodium dodecyl sulfate (SDS) gel loading buffer (100 mMwith or without 50 U/ml IL-2.
Tris-HCl [pH 6.8], 200 mM dithiothreitol, 4% SDS, 0.2%bromophenol
blue, and 20% glycerol).Assays for Apoptosis
Twenty microliters of sample was added to each lane on theActivated T cells (106) were cultured in duplicate wells coated with
SDS±polyacrylamide gel electrophoresis (SDS-PAGE) gels. Sister1 mg/ml anti-CD3, in the presence or absence of 50 U/ml IL-2. In
gels were run for the Western blots: 12% SDS-PAGE for Fas andsome experiments, 106 T cells were incubated for 30 min at 48C with
15% SDS-PAGE for FADD. For FLIP Western blots, whole-cell ly-1 mg/ml anti-Fas antibody (Jo2, PharMingen, San Diego, Ca) or
sates were electrophoresed in 12% SDS-PAGE gels. The Westernhamster immunoglobulin G (IgG); washed; and incubated with 1
blot procedures used here consist of transferring the protein to
mg/ml goat anti-hamster IgG (PharMingen), with or without IL-2.
polyvinylidene difluoride membranes (New England Nuclear, Bos-Controls included cells cultured in medium or IL-2 alone. Cells were
ton, MA) as previously described (Sambrook, 1989). Membranescollected 20±24 hr later, washed in phosphate-buffered saline (PBS)
were blocked overnight in 5% nonfat dry milk dissolved in 13 Tris-
plus 0.1% D-glucose; fixed in 70% ethanol for 12 hr at 48C; and
buffered saline plus 0.05% Tween-20 (Sigma) at 48C. Blots were
incubated in 50 mg/ml propidium iodide for 30 min at room tempera-
then rinsed in 13 Tris-buffered saline plus 0.05% Tween-20 three
ture. Apoptosis was determined by flow cytometry using a Becton
times and incubated with the primary antibodies. For murine Fas,
Dickinson FACScalibur, gating on the subdiploid population. we used 7C10 (a generous gift from B. Stanger [Stanger et al., 1995]),
followed by a horseradish peroxidase (HRP)±conjugated goat anti-
Phenotypic Analysis rat immunoglobulin antibody (ICN Biochemicals, Costa Mesa, CA).
The surface expression of Fas was assayed by staining cells with For FADD, we used a rabbit polyclonal antibody made to human
fluorescein isothiocyanate (FITC)±conjugated anti-Fas andphycoer- FADD (a generous gift from V. Dixit), followed by HRP-conjugated
ythrin (PE)±conjugated anti-CD4 (PharMingen) on ice for 30 min. goat anti-rabbit immunoglobulin. For FLIP, we used a rabbit poly-
Cells were washed and fixed in 1% paraformaldehyde. Staining for clonal antibody (L109) made to human FLIP (Irmler et al., 1997),
FasL was done using a biotinylated rat anti-murine FasL (A11; Hahne followed by HRP-conjugated goat anti-rabbit immunoglobulin.
et al., 1995), followed by fluorescein isothiocyanate±conjugated Western blots were developed using enhanced chemilumines-
streptavidin and PE-conjugated anti-CD4. All samples were ana- cence (ECL kit, Amersham, Buckinghamshire, England), following
lyzed by flow cytometry. the manufacturer's specifications. Size markers used in SDS-PAGE
gels were prestained molecular weight markers (High and Low,
RT-PCR Assays Gibco±BRL).
Cells that were activated as indicated were frozen at 2808C as
pellets. All RNA extractions were done simultaneously for all sam- RNAse Protection Assays
ples in a given experiment. RNA was extracted from about 106 cells RNA was extracted from 107 3A9/IL-22/2 T cells activated with anti-
from each group, using Trizol reagent (Gibco±BRL) according to the CD3 plusanti-CD28 with or without IL-2, using Trizol reagent (Gibco±
manufacturer's instructions. The resulting RNA was reverse tran- BRL). The RNAse protection was performed using 5 mg of RNA with
scribed by adding one third of the total RNA in a volume of 7.5 ml the RiboQuant multi-probe RNAse protection assay system (Phar-
to 1.5 ml of dNTPs (10 nM), 0.5 ml of RNAsin (Promega, Madison, Mingen), following the manufacturer's specifications. In brief, RNA
WI), 0.5 ml DTT (100 mM), 0.5 ml oligo d(T), 3 ml of 53 reaction buffer, was hybridized overnight with the in vitro±translated 32P-labeled
and 1.5 ml of murine Moloney leukemia virus reverse transcriptase probe (mAPO-3 kit, PharMingen). Following hybridization, samples
(MMLV-RT, Gibco±BRL). Samples were incubated at 428C for 2 hr, were treated with RNase A and proteinase K, phenol/chloroform
phenol-chloroform extracted twice, and precipitated in ethanol. The extracted, and ethanol precipitated. The protected fragments were
cDNA pellet was resuspended in 40 ml of diethyl pyrocarbonate± resolved by electrophoresis on a 5% acrylamide/urea gel, and auto-
treated water. The reaction mixture consisted of 4 ml of cDNA tem- radiograms were exposed for 48 hr.
plate, 4 ml of 50 mM MgCl2, 2 ml of 10 nM dNTPs, 2 ml of each primer
(10 ng/ml), 32.5 ml of distilled-deionized water, 0.5 ml of Taq-DNA Retroviral Constructs and T Cell Infection
polymerase (5 U/ml), and 5 ml of 103 PCR buffer (Gibco±BRL). FLIP cDNA (Irmler et al., 1997) was cloned into MSCV-IRES-PLAP
(from J. Jacob, Massachusetts Institute of Technology, Cambridge,The PCR protocol consisted of 1 min at 948C, 1 min at 598C, 1.5 min
Immunity
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MA) upstream of the internal ribosome entry site (IRES). High-titer Golstev, Y.V., Kovalenko, A.V., Arnold,E., Vafolomeev, E.E., Brodian-
skii, V.M., and Wallach, D. (1997). CASH, a novel caspase homologueretrovirus was generated by transient tranfection of the BOSC 23
with death effector domains. J. Biol. Chem. 272, 19641±19644.packaging cell line (Pear et al., 1993). 3A9/1 T cells were activated
with 1 mg/ml of anti-CD3 and anti-CD28. After 24 hr of activation, Hahne, M., Peitsch, M.C., Irmler, M., SchroÈ ter, M., Lowin, B., Rous-
T cells were spun at 2500 rpm for 1.5 hr at 308C in the presence of seau, M., Bron, C., Renno, T., French, L., and Tschopp, J. (1995).
supernatant derived from transfected BOSC 23 cells supplemented Characterization of the non-functional Fas ligand of gld mice. Int.
with 4 mg/ml polybrene (Sigma). This procedure was repeated 24 Immunol. 7, 1381±1386.
hr later. After 72 hr of activation, T cells were collected and cultured Hu, S., Vicenz, C., Ni, J., Genz, R., and Dixit, V.M. (1997). I-FLICE,
in duplicate wells coated with 1 mg/ml anti-CD3 in the presence or a novel inhibitor of tumor necrosis factor receptor-1- and CD95-
absence of 50 U/ml IL-2. The induction of apoptosis in infected and induced apoptosis. J. Biol. Chem. 272, 17255±17257.
noninfected T cells was assayed 20 hr later by surface staining with
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofman, K., Steiner,an antibodyto human PLAP (Zymed)and TdT-mediated dUTP-biotin
V., Bodmer, J.L., SchroÈ ter, M., Burns, K., Mattmann, C., et al. (1997).nick-end labeling (TUNEL) (Boehringer Mannheim), following the
Inhibition of death receptor signals by cellular FLIP. Nature 388,
manufacturers' specifications. In brief, treated cells, which had been
190±195.
surface stained for PLAP, were washed twice in PBS supplemented
Ju, S.T., Panka, D.J., Cui, H., Ettinger, R., E-Khatbl, M., Sherr, D.H.,with 1% bovine serum albumin (Sigma) and permeabilized in 0.1%
Stanger, B.Z., and Marshack-Rothstein, A. (1995). Fas(CD95)/FasLTriton X-100 (Boehringer Mannheim) in 0.1% sodium citrate (Sigma).
Interactions required for programmed cell death after T-cell activa-TUNEL staining was performed using 50 ml of TUNEL mix per sam-
tion. Nature 373, 444±448.ple, at 378C for 1 hr. Cells were then washed in PBS and analyzed
Kneitz, B., Herman, T., Yonehara, S., and Schimpl, A. (1995). Normalby flow cytometry on a FACScalibur apparatus (Becton Dickinson),
clonal expansion but impaired Fas-mediated cell death and anergygating on populations expressing high and low levels of PLAP.
in IL-2 deficient mice. Eur. J. Immunol. 25, 2572±2577.
Latinis, K.M., Carr, L.L., Peterson, E.J., Norian, L.A., Eliason, S.L.,Acknowledgments
and Koretzky, G.A. (1997). Regulation of CD95 (Fas) Ligand expres-
sion by TCR-mediated signaling events. J. Immunol. 158, 4602±The authors thank Joshy Jacob for his generous gift of the MSCV-
4611.IRES-PLAP construct. This work was supported by National Insti-
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cytes for apoptosis. Nature 353, 858±861.and CA51462 (L. V. P.) and a predoctoral fellowship from the Howard
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